|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| MPS IH (Hurler Syndrome) | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Mucopolysaccharidosis I | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Carbohydrate Metabolism, Inborn Errors | |||||
| Connective Tissue Diseases | |||||
| Disease | |||||
| Genetic Diseases, Inborn | |||||
| Lysosomal Storage Diseases | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| Mucinoses | |||||
| Mucopolysaccharidoses | |||||
| Pathologic Processes | |||||
| 4 | Interventions listed in this trial | ||||
| IRT Laronidase | |||||
| 5 | Sponsors listed in this trial | ||||
| University of Minnesota | |||||
| Masonic Cancer Center, University of Minnesota | |||||